Tyskland - tysk - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

kohlpharma gmbh (3216120) - clomipraminhydrochlorid - dragees - teil 1 - dragees; clomipraminhydrochlorid (07233) 10 milligramm

Singapore - engelsk - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - clomipramine hcl - tablet, film coated - 75 mg - clomipramine hcl 75 mg

Irland - engelsk - HPRA (Health Products Regulatory Authority)

novartis pharmaceuticals uk ltd - clomipramine hydrochloride - capsule - 50 milligram(s) - non-selective monoamine reuptake inhibitors; clomipramine

Irland - engelsk - HPRA (Health Products Regulatory Authority)

novartis pharmaceuticals uk ltd - clomipramine hydrochloride - capsule - 10 milligram(s) - non-selective monoamine reuptake inhibitors; clomipramine

Irland - engelsk - HPRA (Health Products Regulatory Authority)

novartis pharmaceuticals uk ltd - clomipramine hydrochloride - capsule - 25 milligram(s) - non-selective monoamine reuptake inhibitors; clomipramine

Israel - engelsk - Ministry of Health

tzamal bio-pharma ltd - clomipramine hydrochloride - tablets slow release - clomipramine hydrochloride 75 mg - clomipramine - clomipramine - depression of varying origin: in children and adolescents there is not sufficient evidence of safety and efficacy of anafranil in the treatment of depressive states of varying aetiology and symptomatology. the use of anafranil in children and odolescents ( 0 - 17 years of age ) in this indication is therefore not recommended. obsessive compulcive syndromes: no experience is available in children younger than 5 years of age.

Israel - engelsk - Ministry of Health

tzamal bio-pharma ltd - clomipramine hydrochloride - coated tablets - clomipramine hydrochloride 25 mg - clomipramine - clomipramine - depression of varying origin: in children and adolescents there is not sufficient evidence of safety and efficacy of anafranil in the treatment of depressive states of varying aetiology and symptomatology. the use of anafranil in children and odolescents ( 0 - 17 years of age ) in this indication is therefore not recommended. obsessive compulcive syndromes: no experience is available in children younger than 5 years of age.

Italia - italiensk - AIFA (Agenzia Italiana del Farmaco)

alfasigma s.p.a. - clomipramina - clomipramina

Spania - spansk - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

alfasigma s.p.a. - clomipramina hidrocloruro - solucion inyectable y para perfusion - 25 mg - clomipramina hidrocloruro 12.5 mg - clomipramina

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

clomipramine hydrochloride -